alpha-aminopyridine has been researched along with Cardiac Conduction Defect in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, CS; Chen, SA; Chen, YC; Chen, YJ; Higa, S; Huang, JH; Lin, FZ; Lin, YK; Liu, CM; Lu, YY; Wu, CI | 1 |
| Ball, S; Sultan, A; Swarup, S; Thein, KZ | 1 |
1 review(s) available for alpha-aminopyridine and Cardiac Conduction Defect
| Article | Year |
|---|---|
Increased risk of cardiac conduction abnormalities with ribociclib in patients with metastatic breast cancer: A combined analysis of phase III randomized controlled trials.
Topics: Aminopyridines; Breast Neoplasms; Cardiac Conduction System Disease; Clinical Trials, Phase III as Topic; Female; Humans; Neoplasm Metastasis; Purines; Randomized Controlled Trials as Topic; Risk Factors | 2021 |
1 other study(ies) available for alpha-aminopyridine and Cardiac Conduction Defect
| Article | Year |
|---|---|
The AMP-activated protein kinase modulates hypothermia-induced J wave.
Topics: Action Potentials; Adenylate Kinase; Aminopyridines; Animals; Cardiac Conduction System Disease; Cold Temperature; Electrocardiography; Enzyme Activators; Glyburide; Heart; Hypothermia; Isolated Heart Preparation; KATP Channels; Rabbits | 2020 |